Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

İzzet Dogan,Didem Tastekin,Senem Karabulut,Burak Sakar

Temozolomide and capecitabine (CAPTEM) is effective in metastatic well-differentiated gastrointestinal neuroendocrine tumors.

2021

İzzet Dogan
Didem Tastekin
Senem Karabulut
Burak Sakar

366Background: The study aimed to evaluate patients' outcomes and prognosis with metastatic gastrointestinal neuroendocrine tumors (mgNET) who treated temozolomide and capecitabine (CAPTEM). Method...

Keywords:

Temozolomide
Internal medicine
Oncology
well differentiated
Medicine
Neuroendocrine tumors
Capecitabine

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations